Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

- August 12th, 2021

Johnson & Johnson will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15 th .  Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. . This webcast will be available to investors and other interested …

– Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15 th .  Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

A webcast replay will be available approximately 48-hrs after the live webcast.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson–johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-301354365.html

SOURCE Johnson & Johnson

News Provided by PR Newswire via QuoteMedia

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Tags

Leave a Reply